Blog

June 23, 2023

By: admin

Reasons to choose List Labs as your Microbiome CDMO: We support a very diverse offering in Bacterial Manufacturing. We are a passionate and transparent CDMO. We are flexible and cohesive enough to be an extension of our customer's team. We offer end-to-end solutions for our customers. Learn more about List Labs' 45 years of experience [...]

November 10, 2022

By: admin

CDMO Services spotlight interview: List Labs

This interview between Jessica Thompson from Kisaco Research and Stacy Burns-Guydish, PhD, President of List Labs, talks about the growth of the Microbiome field for Microbiome CDMOs and digs deep into the Live Biotherapeutics side of this burgeoning industry. To get further insight into the future of the Microbiome field, check out the video below: […]

September 19, 2022

By: admin

cGMP Manufacturing Phase 1, 2, 3 & Commercial

List Labs is an experienced contract development and manufacturing organization (CDMO) harnessing bacteria’s potential for a healthier world. We offer a refreshingly flexible approach to clients seeking a CDMO for Live Biotherapeutic Products (LBP) derived from beneficial bacteria. Partner with List Labs as your CDMO and experience our uniquely collaborative and transparent culture. With over […]

August 30, 2021

By: douano@listlabs.com

List Labs currently has a GMP compliant version of HPT™ Lipopolysaccharide from Escherichia coli O113 in stock. What this means for you: You don’t need to buy an entire batch of lipopolysaccharide or wait months for production and release – Saves you valuable time Paying for as few as 50 vials of a proven product and purchasing […]

August 18, 2021

By: admin

Overcoming Obstacles in the development of Live Biotherapeutic Products

I’d like to tell you about some of the obstacles you may encounter as you develop your live biotherapeutic product (LBP) and how List Labs can help you navigate through them. Harnessing bacteria’s potential for a healthier world is our company mission.  Our history and experience have been devoted to bacteria – what bacteria can produce […]

December 10, 2018

By: admin

A fast, sensitive, specific and accurate detection method to determine active infection Dr. Nancy Shine (408) 874-1305 NShine@ListLabs.com [Campbell, CA, 11/29/2018] • Method to detect Anthrax before it’s deadly • Anthrax is a problem for livestock • Test method is both specific and sensitive for Anthrax • List Labs is looking to partner on this […]

June 22, 2018

By: douano@listlabs.com

By: Rachel Berlin, Marketing Manager Microbiome research is uncovering the enormous potential for developing drugs, such a live biotherapeutic products, from the microbiome.  This burgeoning field is the future of medicine. List Labs is excited and proud to support microbiome research by providing reagents to scientists studying the human microbiome. Below is a list of microbiome […]

June 4, 2018

By: douano@listlabs.com

By: Rachel Berlin, Marketing Manager List Labs is proud to be exhibiting at the Microbiome Drug Develoment Summit 2018 in Boston, MA. The conference will be held at the Boston Seaport World Trade Center from June 20-22. This conference provides access to the latest preclinical, clinical and commercial case studies from the brightest minds in biopharma […]

May 18, 2018

By: douano@listlabs.com

By: Rachel Berlin, Marketing Manager 1978 was a great year for scientific advancement – NASA hired the first women astronauts, the first test tube baby was born and List Labs was founded. Linda Shoer, our founder, saw an opportunity when she realized there was a need for a commercial supplier of Cholera Toxin for studies […]

April 9, 2018

By: douano@listlabs.com

By: Stacy Burns-Guydish, Ph.D., Senior Director, Production The terms “Microbiome” and “live biotherapeutics” have been repeated frequently in the last few years in scientific circles. Researchers are understanding more and more about the various microbiomes in the human body and how they affect our overall health. From this research, microorganisms have been identified that may […]

March 27, 2018

By: douano@listlabs.com

By: Rachel Berlin, Marketing Manager List Labs is proud to be exhibiting at the 4th Annual Translational Microbiome Conference April 18-20 at the Boston Marriott Long Wharf. List Labs has extensive experience with microbiome and more specifically live biotherapeutic projects including vaginal, gut, skin and the central nervous system indication and tumor treatment – many of […]

February 20, 2018

By: douano@listlabs.com

By: Nancy Shine, PhD, Director of R&D, List Labs A fast, sensitive, specific and accurate detection method to determine active infection by Bacillus anthracis in plasma has been developed at List Biological Laboratories. Bacillus anthracis is regarded as a major biological warfare threat. The inhalation form of Bacillus anthracis infection can kill quickly.  While antibiotic […]

January 23, 2018

By: douano@listlabs.com

By: Rachel Berlin, Marketing Manager List Labs is proud to be exhibiting at ASM Biothreats February 12-14th. The conference will be held in Baltimore, Maryland at the Hilton Hotel. Thought leaders in academia, industry and government will gather to present and discuss the latest developments in the emerging field of biothreats. This year’s conference has […]

December 11, 2017

By: douano@listlabs.com

By: Rachel Berlin, Marketing Manager List Labs provides expert GMP contract manufacturing services to aid you in developing product for your clinical trial. The List Labs difference is that we manufacture reagent grade biological toxins regularly for resale, which means that not only do we have current, state-of-the art facilities and equipment, but we also […]

August 29, 2017

By: dpinkston@listlabs.com

The origin of businesses is often an interesting story. List Biological Laboratories is no exception. The company was founded in 1978 by Linda Shoer. Linda was an entrepreneurial scientist in Silicon Valley, who’d been relocated with her husband from Boston. She had an idea for a company and leveraged an initial order into a loan […]

August 7, 2017

By: douano@listlabs.com

By: Mary N. Wessling, Ph.D. ELS   What is Lyophilization? Protecting the activity of enzyme products and the viability of bacterial cultures that are used in scientific experimentation is an area where List Biological Laboratories is a leader. Lyophilization has been the most extensively used technique for maintaining the integrity of biopharmaceuticals. Lyophilization (otherwise known […]

May 15, 2017

By: douano@listlabs.com

By: Stacy Burns-Guydish, Ph.D., Senior Director, Microbiology The human body is home to a vast ecosystem of microbes, called the microbiome.  Research is shedding light on the importance of the microbiome as a benefactor to our health and development.  Perturbation of the microbiome has been associated with a growing number of diseases including inflammatory bowel […]

June 14, 2016

By: douano@listlabs.com

By: Debra Booth, VP of Operations Linda Eaton, Ph.D., VP of Research & Development Stacy Burns-Guydish, Ph.D., Senior Director of Microbiology PJ Nehil, Sales & Distribution Coordinator Dear Researchers Everywhere, List Labs recently exhibited at the 2016 BIO International Convention. As a producer of bacterial products for research, as well as a provider of custom […]

May 16, 2016

By: douano@listlabs.com

UPDATE: July 13, 2016 Alpha Toxin from C. septicum, product #116L is now available for purchase online. Information on other potential upcoming products can be found on our Product Pipeline. UPDATE: May 16, 2016 Alpha Toxin from C. septicum is currently in late to final stages of development, and we are accepting orders now. We expect to ship […]

April 11, 2016

By: douano@listlabs.com

Dr. Karen Crawford, President of List Biological Laboratories, Inc. We will be exhibiting at the 2nd Annual Translational Microbiome Conference at the Hilton Boston Back Bay on April 20-21. We are also proud to be a sponsor of this event. If you will be in attendance, stop by the List Labs booth and chat with Karen Crawford about […]

June 22, 2015

By: douano@listlabs.com

By: Karen Crawford, Ph.D., President Eva Purro, Director of Quality Assurance Dom C. Ouano, Marketing While most of List Labs’ products are intended as research reagents (Research Grade), several can be produced as GMP products for use in humans. Below are key differences between the two. Research Only VS Preclinical/Clinical/Human Use Reagent grade products for […]

March 16, 2015

By: admin

By: Suzanne Canada, Ph.D. Tanager Medical Writing While you go about your day, you are surrounded by micro-organisms.  Although most of us spend a lot of time washing up and trying not to think about the propensity of creatures that share our personal space, scientists have been studying them.  Due to their great progress, we […]

January 12, 2015

By: admin

Fundastic believes in being objective and transparent when it comes to funding and financing for small businesses. The following is an interview between Fundastic writer Sarah Tang and List Labs President Dr. Karen Crawford. View the original post here. By: Sarah Tang Fundastic Business Owner Stories Dr. Karen Crawford is the president of List Labs, a manufacturing […]

July 17, 2014

By: dpinkston@listlabs.com

Volume Discounts on Toxins and Reagents List Laboratories has been in business since 1978.  We’ve been providing our customers with quality toxins and custom manufacturing services for decades.    We want to make it easier for everyone within your company to purchase and receive the best value for those purchases. We have recently begun a […]

May 8, 2014

By: dpinkston@listlabs.com

Since 1978, List Labs has been known as a manufacturer of fine research reagents.  Located in Silicon Valley, our company is woman-owned and managed.  We enjoy long-standing relationships with many researchers who have used our products for decades, bringing the continuity of List’s products along with them as they move up to new career opportunities. Full Range of Contract […]